Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, cancer, diabetes, hepatitis C, HIV/AIDs and more.  Interruptions in treatment can lead to disease progression and unnecessary medical expenses like hospitalization or surgery…

Placing patients at the center of everything the biotech industry stands for is a personal mission for Christi Shaw. In 1996, her mother, Karen, died of breast cancer. It was a tragic time for her and her two sisters. But tragedy would strike again as Christi’s sister, Sherry, was later diagnosed…

In a world of continual innovation in biopharmaceuticals, how do we ensure patients have access to the medicines that work to meet their individual needs? To discuss this important issue, we sat down with Merck Chief Patient Officer Dr. Julie Gerberding to discuss how we can better understand the…

Summary: BIO CEO Jim Greenwood gave the following keynote address at the BIO 2019 International Convention today in Philadelphia, highlighting how politicians and patients are talking about different things when discussing drug costs in the United States and why represents a threat to…

Jesse Gelsinger was an Arizona teenager who loved motorbikes and making people laugh. What makes him a Philadelphia story? A rare disease of the liver. Patients with ornithine transcarbamylase deficiency (OTCD) lack the enzyme that breaks down ammonia, which occurs naturally when your body breaks…

This past March, BIO launched DrugCostFacts.org, an interactive web tool designed to help policymakers, members of the media and the broader public access the best facts surrounding drug costs, spending and value. By featuring a series of commonly asked questions, as well as research and…